Stoke Therapeutics Inc (NASDAQ:STOK)

Delayed Data
As of Jun 09
 -0.98 / -7.72%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Stoke Therapeutics Inc have a median target of 26.00, with a high estimate of 35.00 and a low estimate of 12.00. The median estimate represents a +122.03% increase from the last price of 11.71.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Stoke Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -19.79%
Growthannually 4.59%


Growthquarterly -33.14%
Growthannually 14.17%
Key to the earnings and sales forecast charts.